BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1285@pharmaconomics
DTSTAMP:20260707T030840Z
DTSTART;VALUE=DATE:20260327
DTEND;VALUE=DATE:20260328
SUMMARY:MOLN PDUFA — MP0712
DESCRIPTION:The FDA's approval decision on MP0712 for small cell lung cancer is due Mar 27\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1745114/000117184326000214/exh_991.htm\n\nTrack it: https://pharmaconomics.com/e/1285
URL:https://pharmaconomics.com/e/1285
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:MOLN catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR